ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
Authors
Keywords
Estrogen receptor beta, Breast cancer, Estrogen receptor alpha, Triple negative breast cancer, Therapy
Journal
BMC CANCER
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-10-07
DOI
10.1186/1471-2407-14-749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ERβ splice variant expression in four large cohorts of human breast cancer patient tumors
- (2014) Hallie Wimberly et al. BREAST CANCER RESEARCH AND TREATMENT
- Significance of ERβ expression in different molecular subtypes of breast cancer
- (2014) Liying Guo et al. Diagnostic Pathology
- Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer
- (2014) Bo Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of both Estrogen Receptor-beta 1 (ER-β1) and its co-regulator Steroid Receptor RNA Activator Protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with Estrogen Receptor-alpha (ER-α)-Negative Early Breast Cancer (EBC)
- (2013) Y. Yan et al. ANNALS OF ONCOLOGY
- Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines
- (2013) Claus Lattrich et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
- (2013) Marcelo Madeira et al. BMC CANCER
- Research Resource: Global Identification of Estrogen Receptor β Target Genes in Triple Negative Breast Cancer Cells
- (2013) Erin K. Shanle et al. MOLECULAR ENDOCRINOLOGY
- Integrative genomics of gene and metabolic regulation by estrogen receptors and , and their coregulators
- (2013) Z. Madak-Erdogan et al. Molecular Systems Biology
- Endoxifen’s Molecular Mechanisms of Action Are Concentration Dependent and Different than That of Other Anti-Estrogens
- (2013) John R. Hawse et al. PLoS One
- The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression
- (2012) Zhenzhen Tu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells
- (2012) C Z Cotrim et al. ONCOGENE
- Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer
- (2012) M Razandi et al. ONCOGENE
- Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody
- (2011) Xianglin Wu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer
- (2011) H Raza Ali et al. JOURNAL OF PATHOLOGY
- Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis
- (2011) Mohammad H Forouzanfar et al. LANCET
- Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers
- (2010) Max Yan et al. BREAST CANCER RESEARCH AND TREATMENT
- Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors
- (2010) Kazuyoshi Motomura et al. ONCOLOGY
- Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2009) Jonathan D Marotti et al. MODERN PATHOLOGY
- Expression and subcellular distribution of native estrogen receptor β in murine C2C12 cells and skeletal muscle tissue
- (2009) Lorena Milanesi et al. STEROIDS
- Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
- (2008) Maria M Litwiniuk et al. BMC CANCER
- Nuclear and Cytoplasmic Expression of ER 1, ER 2, and ER 5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients
- (2008) A. M. Shaaban et al. CLINICAL CANCER RESEARCH
- Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy
- (2008) Naoko Honma et al. JOURNAL OF CLINICAL ONCOLOGY
- Influence of Cellular ERα/ERβ Ratio on the ERα-Agonist Induced Proliferation of Human T47D Breast Cancer Cells
- (2008) Ana Maria Sotoca Covaleda et al. TOXICOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More